Updated on 2025/05/22

写真b

 
OHTAWA,MASAKI
 
*Items subject to periodic update by Rikkyo University (The rest are reprinted from information registered on researchmap.)
Affiliation*
College of Science Department of Chemistry
Graduate School of Science Doctoral Program in Chemistry
Graduate School of Science Master's Program in Chemistry
Title*
Associate Professor
Degree
修士(薬学) ( 北海道大学 ) / 博士 (薬学) ( 北里大学 )
Contact information
Mail Address
Research Interests
  • 天然物合成化学

  • 有機合成化学

  • 創薬化学

  • Campus Career*
    • 4 2025 - Present 
      College of Science   Department of Chemistry   Associate Professor
    • 4 2025 - Present 
      Graduate School of Science   Master's Program in Chemistry   Associate Professor
    • 4 2025 - Present 
      Graduate School of Science   Doctoral Program in Chemistry   Associate Professor
     

    Research Areas

    • Nanotechnology/Materials / Synthetic organic chemistry

    • Life Science / Pharmaceutical chemistry and drug development sciences  / Drug Development Chemistry

    • Life Science / Pharmaceutical chemistry and drug development sciences  / Chemical Pharmaceutical Science

    • Life Science / Pharmaceutical chemistry and drug development sciences  / 有機合成化学

    Research History

    • 4 2025 - Present 
      北里大学大学院感染制御科学府   非常勤講師

      More details

    • 4 2025 - Present 
      Rikkyo University   Department of Chemistry, College of Science

      More details

    • 4 2020 - 3 2025 
      Kitasato University   School of Pharmaceutical Sciences

      More details

    • 1 2015 - 3 2020 
      Kitasato University   School of Pharmaceutical Sciences

      More details

    • 4 2016 - 3 2018 
      Scripps Research   Department of Chemistry

      More details

    • 4 2008 - 12 2014 
      Kitasato University   School of Pharmaceutical Sciences

      More details

    • 4 2013 - 12 2013 
      Keio University   Faculty of Science and Technology

      More details

    • 4 2007 - 3 2008 
      Kitasato University   School of Pharmaceutical Sciences

      More details

    ▼display all

    Education

    • 2005 - 2007 
      北海道大学大学院   薬学研究院   博士前期課程

      More details

    • 2001 - 2005 
      Kitasato University   School of Pharmaceutical Sciences   Faculty of Pharmaceutical Technology

      More details

    Committee Memberships

    • 4 2020 - Present 
      次世代を担う有機化学シンポジウム世話人

      More details

    • 4 2021 - 3 2025 
      学校法人北里研究所人権相談員

      More details

    • 5 2024 
      第22回次世代を担う有機化学シンポジウム実行委員

      More details

    Awards

    • 2025  
      2025年度日本薬学会化学系薬学部会賞 

      More details

    • 2025  
      第22回森村豊明会奨励賞 

      More details

    • 2021  
      北里大学薬学部優秀教育賞 

      More details

    • 2021  
      有機合成化学協会  2021年帝人ファーマ研究企画賞 

      More details

    • 2021  
      日本薬学会関東支部奨励賞 

      More details

    • 2020  
      北里大学同窓会研究奨励賞 

      More details

    • 2019  
      北里大学薬学部  優秀教育賞 

      More details

    • 2015  
      公益財団法人 上原記念生命科学財団  リサーチフェローシップ (2年助成) 

      More details

    • 2015  
      北里大学薬学部  優秀教育賞 

      More details

    • 2013  
      第31回メディシナルケミストリーシンポジウム優秀賞 

      More details

    ▼display all

    Papers

    • Total Synthesis and Determination of the Absolute Configuration of Shodoamide C: An Amphotericin B Potentiator against Candida albicans. Peer-reviewed International journal

      Shogo Ueki, Akihiro Hirata, Akiho Yagi, Masahiro Iwahori, Hiroshi Tomoda, Ryuji Uchida, Tohru Nagamitsu, Masaki Ohtawa

      Organic letters27 ( 14 ) 3777 - 3781   2 4 2025

      More details

      Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

      The total synthesis and structural determination of shodoamide C (1), a compound that enhances the activity of amphotericin B against Candida albicans, have been achieved. A synthetic strategy for compound 1 facilitated the efficient synthesis of all 16 stereoisomers, allowing for the identification of the four previously unknown stereocenters of 1 through the chiral recycle HPLC analyses. All stereoisomers of 1 showed similar activity, indicating that their stereochemistries minimally influenced it.

      DOI: 10.1021/acs.orglett.5c01017

      PubMed

      researchmap

    • Concise syntheses of (−)-habiterpenol and (+)-2,3-<i>epi</i>-habiterpenol <i>via</i> redox radical cyclization of alkenylsilane Peer-reviewed

      Haruki Taguchi, Mayuko Kawaguchi, Tohru Nagamitsu, Masaki Ohtawa

      Organic and Biomolecular Chemistry21   6129 - 6133   7 2023

      More details

      Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry (RSC)  

      The concise synthesis of (−)-habiterpenol in 11 steps was enabled by MHAT-initiated redox radical cyclization of alkenylsilane.

      DOI: 10.1039/d3ob01062g

      researchmap

    • MHAT-initiated redox radical cyclization of alkenylsilane enables concise syntheses of (–)-habiterpenol and (+)-2,3-epi-habiterpenol

      Haruki Taguchi, Mayuko Kawaguchi, Tohru Nagamitsu, Masaki Ohtawa

          17 4 2023

      More details

      Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society (ACS)  

      The concise syntheses of (–)-habiterpenol and (+)-2,3-epi-habiterpenol from (3aR)-(+)-sclareolide and 6-methoxyindanone in 11 and 12 steps, respectively, was enabled by the regioselective addition of the TMS-indenyl anion and facile stereoselective MHAT-initiated redox radical cyclization of alkenylsilane.

      DOI: 10.26434/chemrxiv-2023-c4w8x

      researchmap

    • One-pot γ-lactonization of homopropargyl alcohol via intramolecular ketene trapping. 〜Its discovery, optimization, and application〜 Invited

      Masaki Ohtawa

      TCI MAIL192   2 - 10   3 2023

      More details

      Authorship:Lead author, Last author, Corresponding author   Language:Japanese   Publishing type:Research paper (scientific journal)  

      researchmap

    • Comprehensive Studies on the Synthetic Organic Chemistry of Unique Bioactive Natural Products; Total Synthesis, Drug Discovery, and Development of New Reactions Invited Peer-reviewed

      Masaki Ohtawa

      YAKUGAKU ZASSHI142 ( 10 ) 1067 - 1075   1 10 2022

      More details

      Authorship:Lead author, Last author, Corresponding author   Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Pharmaceutical Society of Japan  

      DOI: 10.1248/yakushi.22-00118

      researchmap

    • Concise Syntheses of (−)-11-O-Debenzoyltashironin and (−)-Bilobalide Peer-reviewed

      Masaki Ohtawa, Ryan A. Shenvi

      Journal of Synthetic Organic Chemistry, Japan80 ( 8 ) 766 - 777   1 8 2022

      More details

      Authorship:Lead author, Corresponding author   Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:The Society of Synthetic Organic Chemistry, Japan  

      DOI: 10.5059/yukigoseikyokaishi.80.766

      researchmap

    • Synthesis and Evaluation of Habiterpenol Analogs Peer-reviewed

      Miyuki Konya, Shiho Arima, Daiki Lee, Masaki Ohtawa, Kenta Shimoyama, Takashi Fukuda, Ryuji Uchida, Hiroshi Tomoda, Noriyuki Yamaotsu, Nobutada Tanaka, Tohru Nagamitsu

      Chemical and Pharmaceutical Bulletin70 ( 4 ) 261 - 268   1 4 2022

      More details

      Language:English   Publishing type:Research paper (scientific journal)   Publisher:Pharmaceutical Society of Japan  

      Habiterpenol is a G2 checkpoint inhibitor isolated from the culture broth of Phytohabitans sp. 3787_5. Here, we report the synthesis of new habiterpenol analogs through the total synthesis process of habiterpenol and evaluating the analogs for G2 checkpoint inhibitory activity. We investigated two different synthetic approaches for total synthesis, with intramolecular conjugate addition and Ti(III)-mediated radical cyclization as key reactions. Although the former was unsuccessful, the latter reaction facilitated stereoselective total synthesis and determination of the absolute configuration of habiterpenol. The extension of these chemistries to a structure-activity relationship (SAR) study gave new habiterpenol analogs, which could not be derived from natural habiterpenol and only be synthesized by applying the total synthesis. Therefore, this study provides important insights into SAR studies of habiterpenol.

      DOI: 10.1248/cpb.c21-00993

      PubMed

      researchmap

    • Mixture of clopidogrel bisulfate and magnesium oxide tablets reduces clopidogrel dose administered through a feeding tube Peer-reviewed

      Manahito Aoki, Midori Naya, Shiho Arima, Kaori Shinohara, Masahiro Kato, Kiyoshi Shibuya, Masaki Ohtawa, Tohru Nagamitsu, Katsuya Otori

      Journal of Pharmaceutical Health Care and Sciences7 ( 1 )   12 2021

      More details

      Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

      <title>Abstract</title><sec>
      <title>Background</title>
      In clinical practice, a mixed suspension of clopidogrel bisulfate and magnesium oxide (MgO) tablets is administered frequently via a feeding tube. However, there is no report on the changes occurring when suspensions of these two drugs are combined, including the effects or potential decrease in dose following tube administration. Thus, the purpose of our study was to investigate the (i) changes caused by mixing clopidogrel bisulfate (ion form) and MgO tablets and (ii) effects on the administered clopidogrel dose after passing through a feeding tube.


      </sec><sec>
      <title>Methods</title>
      The molecular structure of clopidogrel generated in a mixture of clopidogrel bisulfate and a basic compound, such as sodium bicarbonate or MgO tablet, was determined by <sup>1</sup>H-NMR after extraction and purification. The suspension of clopidogrel bisulfate tablet alone and the mixed suspension of clopidogrel bisulfate tablet and MgO tablet were passed through a feeding tube. We compared the yield of the molecular form of clopidogrel from each passed fraction.


      </sec><sec>
      <title>Results</title>
      The substance obtained from the mixture of clopidogrel bisulfate tablet and sodium bicarbonate or MgO tablet was identified as the molecular form of clopidogrel, and chemical degradation did not occur under these conditions. In the tube passage test, the yield of clopidogrel (molecular form) from the mixture of clopidogrel bisulfate and MgO tablets was lower than that from the suspension of clopidogrel bisulfate tablet alone.


      </sec><sec>
      <title>Conclusions</title>
      The mixture of clopidogrel bisulfate and MgO tablets caused a considerable reduction in the administered dose passed through the feeding tube. Therefore, it is recommended to administer the suspensions of clopidogrel bisulfate and MgO tablets separately for safe and effective pharmacotherapy.


      </sec>

      DOI: 10.1186/s40780-021-00202-1

      researchmap

      Other Link: https://link.springer.com/article/10.1186/s40780-021-00202-1/fulltext.html

    • One-Pot γ-Lactonization of Homopropargyl Alcohols via Intramolecular Ketene Trapping Peer-reviewed

      Daichi Yamane, Haruna Tanaka, Akihiro Hirata, Yumiko Tamura, Daichi Takahashi, Yusuke Takahashi, Tohru Nagamitsu, Masaki Ohtawa

      Organic Letters23 ( 7 ) 2831 - 2835   22 3 2021

      More details

      Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society (ACS)  

      DOI: 10.1021/acs.orglett.1c00840

      researchmap

    • Synthetic, Mechanistic, and Biological Interrogation of Ginkgo biloba Chemical Space En Route to (−)-Bilobalide Peer-reviewed

      Robert M. Demoret, Meghan A. Baker, Masaki Ohtawa, Shuming Chen, Ching Ching Lam, Sophia Khom, Marisa Roberto, Stefano Forli, Kendall N. Houk, Ryan A. Shenvi

      Journal of the American Chemical Society   16 10 2020

      More details

      Language:English   Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society ({ACS})  

      DOI: 10.1021/jacs.0c08231

      researchmap

    • Synthesis and Mechanistic Interrogation of Ginkgo biloba Chemical Space en route to (–)-Bilobalide Peer-reviewed

      Masaki Ohtawa

      ChemRxiv   20 4 2020

      More details

      Language:English   Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society ({ACS})  

      <jats:p>Here we interrogate the structurally dense (1.63 mcbits/Å&lt;sup&gt;3&lt;/sup&gt;) GABA&lt;sub&gt;A&lt;/sub&gt; receptor antagonist bilobalide, intermediates en route to its synthesis and related mechanistic questions. &lt;sup&gt;13&lt;/sup&gt;C isotope labeling identified an unexpected bromine migration en route to an α-selective, catalytic asymmetric Reformatsky reaction, ruling out an asymmetric allylation pathway. Experiment and computation converge on the driving forces behind two surprising observations. First, an oxetane acetal is shown to persist in concentrated mineral acid (1.5 M DCl in THF-d&lt;sub&gt;8&lt;/sub&gt;/D&lt;sub&gt;2&lt;/sub&gt;O), and its longevity is correlated to destabilizing steric clashes between substituents. Second, a regioselective oxidation of &lt;i&gt;des&lt;/i&gt;-hydroxybilobalide is found to rely on lactone acidification through lone-pair delocalization, which leads to extremely rapid intermolecular enolate equilibration. In addition, we describe multiple pitfalls, puzzles and unexpected reactions that ultimately uncovered a concise total synthesis. These problems arose from the high information density of bilobalide that distinguishes it from other scaffolds and may characterize natural product (NP) space more generally. Therefore, we also include a Python script to quickly (&lt;i&gt;ca.&lt;/i&gt; 132,000 molecules/ minute) calculate information content (Böttcher scores), which may be helpful to identify important features of NP space.</jats:p>

      DOI: 10.26434/chemrxiv.12132939.v1

      researchmap

    • Repair of DNA damage induced by the novel nucleoside analogue CNDAG through homologous recombination Peer-reviewed

      Xiaojun Liu, Yingjun Jiang, Billie Nowak, Satoshi Ichikawa, Masaki Ohtawa, Akira Matsuda, William Plunkett

      Cancer Chemotherapy and Pharmacology   2020

      More details

      Language:English   Publishing type:Research paper (scientific journal)  

      © 2020, Springer-Verlag GmbH Germany, part of Springer Nature. Purpose: We postulate that the deoxyguanosine analogue CNDAG [9-(2-C-cyano-2-deoxy-1-β-d-arabino-pentofuranosyl)guanine] likely causes a single-strand break after incorporation into DNA, similar to the action of its cytosine congener CNDAC, and that subsequent DNA replication across the unrepaired nick would generate a double-strand break. This study aimed at identifying cellular responses and repair mechanisms for CNDAG prodrugs, 2-amino-9-(2-C-cyano-2-deoxy-1-β-d-arabino-pentofuranosyl)-6-methoxy purine (6-OMe) and 9-(2-C-cyano-2-deoxy-1-β-d-arabino-pentofuranosyl)-2,6-diaminopurine (6-NH2). Each compound is a substrate for adenosine deaminase, the action of which generates CNDAG. Methods: Growth inhibition assay, clonogenic survival assay, immunoblotting, and cytogenetic analyses (chromosomal aberrations and sister chromatid exchanges) were used to investigate the impact of CNDAG on cell lines. Results: The 6-NH2 derivative was selectively potent in T cell malignant cell lines. Both prodrugs caused increased phosphorylation of ATM and its downstream substrates Chk1, Chk2, SMC1, NBS1, and H2AX, indicating activation of ATM-dependent DNA damage response pathways. In contrast, there was no increase in phosphorylation of DNA-PKcs, which participates in repair of double-strand breaks by non-homologous end-joining. Deficiency in ATM, RAD51D, XRCC3, BRCA2, and XPF, but not DNA-PK or p53, conferred significant clonogenic sensitivity to CNDAG or the prodrugs. Moreover, hamster cells lacking XPF acquired remarkably more chromosomal aberrations after incubation for two cell cycle times with CNDAG 6-NH2, compared to the wild type. Furthermore, CNDAG 6-NH2 induced greater levels of sister chromatid exchanges in wild-type cells exposed for two cycles than those for one cycle, consistent with increased double-strand breaks after a second S phase. Conclusion: CNDAG-induced double-strand breaks are repaired mainly through homologous recombination.

      DOI: 10.1007/s00280-020-04035-x

      Scopus

      PubMed

      researchmap

    • Concise asymmetric synthesis of (−)-bilobalide Peer-reviewed

      Baker, M.A., Demoret, R.M., Ohtawa, M., Shenvi, R.A.

      Nature575 ( 7784 ) 643 - 646   16 10 2019

      More details

      Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

      DOI: 10.1038/s41586-019-1690-5

      Scopus

      PubMed

      researchmap

    • Total Synthesis and Absolute Configuration of Simpotentin, a Potentiator of Amphotericin B Activity Peer-reviewed International journal

      Ohtawa Masaki, Shimizu Eri, Saito Atsushi, Sakamoto Sayuri, Waki Ai, Kondo Ariko, Yagi Akiho, Uchida Ryuji, Tomoda Hiroshi, Nagamitsu Tohru

      Organic Letters21 ( 14 ) 5596 - 5599   19 7 2019

      More details

      Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

      The total synthesis of simpotentin (1), a new potentiator of amphotericin B activity against Candida albicans, was achieved. Our research results enabled the access of all stereoisomers of 1 and the elucidation of the unknown absolute configuration of 1. Furthermore, one of the stereoisomers is a better amphotericin B potentiator than 1 and is an excellent lead compound for the development of a novel amphotericin B potentiator.

      DOI: 10.1021/acs.orglett.9b01945

      PubMed

      researchmap

    • Structure-activity relationship studies of atpenin A5 analogs with chemical modification of the side chain moiety Peer-reviewed

      Ohtawa Masaki, Yano Keisuke, Miyao Atsuyoshi, Hiura Tohru, Sugiyama Kouhei, Arima Shiho, Kita Kiyoshi, Omura Satoshi, Nagamitsu Tohru

      TETRAHEDRON LETTERS60 ( 15 ) 1037 - 1042   11 4 2019

      More details

      Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

      DOI: 10.1016/j.tetlet.2019.03.026

      researchmap

    • Total synthesis of 4-epi-atpenin A5 as a potent nematode complex II inhibitor Invited Peer-reviewed

      Lee Daiki, Kondo Hiroki, Kuwayama Yui, Takahashi Kento, Arima Shiho, Omura Satoshi, Ohtawa Masaki, Nagamitsu Tohru

      TETRAHEDRON75 ( 24 ) 3178 - 3185   2 2019

      More details

      Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

      DOI: 10.1016/j.tet.2019.02.050

      researchmap

    • Pharmacological characterization of the neurotrophic sesquiterpene jiadifenolide reveals a non-convulsant signature and potential for progression in neurodegenerative disease studies Peer-reviewed

      Witkin, J.M., Shenvi, R.A., Li, X., Gleason, S.D., Weiss, J., Morrow, D., Catow, J.T., Wakulchik, M., Ohtawa, M., Lu, H.-H., Martinez, M.D., Schkeryantz, J.M., Carpenter, T.S., Lightstone, F.C., Cerne, R.

      Biochemical Pharmacology155   61 - 70   9 2018

      More details

      Language:English   Publishing type:Research paper (scientific journal)  

      DOI: 10.1016/j.bcp.2018.06.022

      Scopus

      researchmap

    • Design and Synthesis of A-Ring Simplified Pyripyropene A Analogues as Potent and Selective Synthetic SOAT2 Inhibitors Peer-reviewed

      Masaki Ohtawa, Shiho Arima, Naoki Ichida, Tomiaki Terayama, Hironao Ohno, Takaya Yamazaki, Taichi Ohshiro, Noriko Sato, Satoshi Omura, Hiroshi Tomoda, Tohru Nagamitsu

      ChemMedChem13 ( 5 ) 411 - 421   6 3 2018

      More details

      Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:John Wiley and Sons Ltd  

      Currently, pyripyropene A, which is isolated from the culture broth of Aspergillus fumigatus FO-1289, is the only compound known to strongly and selectively inhibit the isozyme sterol O-acyltransferase 2 (SOAT2). To aid in the development of new cholesterol-lowering or anti-atherosclerotic agents, new A-ring simplified pyripyropene A analogues have been designed and synthesized based on total synthesis, and the results of structure–activity relationship studies of pyripyropene A. Among the analogues, two A-ring simplified pyripyropene A analogues exhibited equally efficient SOAT2 inhibitory activity to that of natural pyripyropene A. These new analogues are the most potent and selective SOAT2 inhibitors to be used as synthetic compounds and attractive seed compounds for the development of drug for dyslipidemia, including atherosclerotic disease and steatosis.

      DOI: 10.1002/cmdc.201700645

      Scopus

      researchmap

      Other Link: http://orcid.org/0000-0001-7129-012X

    • PRD125, a Highly Potent SOAT2 Inhibitor, Attenuates Both Atherosclerosis and Fatty Liver Progression in Cholesterol Diet-fed Rabbit Peer-reviewed

      Ohshiro Taichi, Ohtawa Masaki, Nagamitsu Tohru, Yagyu Hiroaki, Rudel Lawrence L, Ishibashi Shun, Tomoda Hiroshi

      CIRCULATION136   14 11 2017

      More details

      Language:English   Publishing type:Research paper (scientific journal)  

      researchmap

    • Scopranones with Two Atypical Scooplike Moieties Produced by Streptomyces sp BYK-11038 Peer-reviewed

      Ryuji Uchida, Daiki Lee, Ibuki Suwa, Masaki Ohtawa, Nozomu Watanabe, Ayumu Demachi, Satoshi Ohte, Takenobu Katagiri, Tohru Nagamitsu, Hiroshi Tomoda

      ORGANIC LETTERS19 ( 21 ) 5980 - 5983   11 2017

      More details

      Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

      Three new compounds, designated scopranones A-C, were isolated from the culture broth of a soil isolate, Streptomyces sp. BYK-11038, and shown to be inhibitors of bone morphogenetic protein (BMP) induced alkaline phosphatase activity in a BMP receptor mutant cell line. The structures were elucidated using NMR and other spectral data. The scopranones have an unusual structure with two atypical scooplike moieties linked at the tails to form part of a unique 3-furanone ring.

      DOI: 10.1021/acs.orglett.7b03003

      researchmap

    • Deprotection of silyl ethers by using SO3H silica gel: Application to sugar, nucleoside, and alkaloid derivatives Peer-reviewed

      Hideaki Fujii, Naoyuki Shimada, Masaki Ohtawa, Fumika Karaki, Masayoshi Koshizuka, Kohei Hayashida, Mitsuhiro Kamimura, Kazuishi Makino, Tohru Nagamitsu, Hiroshi Nagase

      TETRAHEDRON73 ( 36 ) 5425 - 5429   9 2017

      More details

      Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

      We applied a desilylation procedure using SO3H silica gel, with the surface modified by alkylsulfonic acid groups, to silylated sugar, nucleoside, and alkaloid derivatives. The treatment with SO3H silica gel provided desilylated products in good to excellent yield. In the reactions of sugar and nucleoside derivatives, no silyl residue was detected in the crude products, but the crude products of the reaction of alkaloids contained small amounts of silyl residues. Even though the sugar and nucleoside derivatives had a labile glycosyl and C-N bond, respectively, these bonds tolerated the reaction conditions. These outcomes suggested that the desilylation procedure using SO3H silica gel would be applicable to the deprotection of a variety of types of compounds protected by silyl groups. In a gram scale experiment, the desilylation procedure successfully proceeded without the observation of any silyl residue in the crude product. (C) 2017 Elsevier Ltd. All rights reserved.

      DOI: 10.1016/j.tet.2017.07.047

      researchmap

    • Synthesis of (-)-11-O-Debenzoyltashironin: Neurotrophic Sesquiterpenes Cause Hyperexcitation Peer-reviewed

      Masaki Ohtawa, Michael J. Krambis, Rok Cerne, Jeffrey M. Schkeryantz, Jeffrey M. Witkin, Ryan A. Shenvi

      JOURNAL OF THE AMERICAN CHEMICAL SOCIETY139 ( 28 ) 9637 - 9644   7 2017

      More details

      Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

      11-O-Debenzoyltashironin (1) is a member of the neurotrophic sesquiterpenes, trace plant metabolites that enhance neurite outgrowth in cultured neurons. We report its synthesis in six steps from a butenolide heterodimer via its likely biosynthetic precursor, 3,6-dideoxy-10-hydroxypseudoanisatin, here identified as the chain tautomer of 1. Access to the tashironin chemotype fills a gap in a comparison set of convulsive and neurotrophic sesquiterpenes, which we hypothesized to share a common target. Here we show that both classes mutually hyperexcite rat cortical neurons, consistent with antagonism of inhibitory channels and a mechanism of depolarization-induced neurite outgrowth.

      DOI: 10.1021/jacs.7b04206

      researchmap

    • Development of a new air-stable structure-simplified nafuredin-gamma analog as a potent and selective nematode complex I inhibitor Peer-reviewed

      Masaki Ohtawa, Shiho Arima, Risa Shimizu, Naomi Hanatani, Eri Shimizu, Kazuro Shiomi, Kiyoshi Kita, Satoshi Omura, Tohru Nagamitsu

      JOURNAL OF ANTIBIOTICS70 ( 5 ) 647 - 654   5 2017

      More details

      Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:JAPAN ANTIBIOTICS RESEARCH ASSOC  

      Nafuredin-gamma, obtained from natural nafuredin, has demonstrated a potent and selective inhibitory activity against nematode complex I. However, nafuredin-gamma is unstable in air since its conjugated dienes are oxygen-labile. The instability in air was naturally solved by the synthesis of structure-simplified nafuredin-gamma analogs without conjugated dienes. However, these modified analogs showed lower complex I inhibitory activities. Therefore, new air-stable structure-simplified nafuredin-gamma analogs were designed and synthesized herein. Among all analogs synthesized, the one bearing a unique 1-azabicyclo[3.1.0] hexane scaffold showed the highest inhibitory activity (IC50 = 170 nM) while presenting high selectivity against nematode complex I.

      DOI: 10.1038/ja.2017.16

      researchmap

    • Synthesis and Structural Revision of Cyslabdan Peer-reviewed

      Masaki Ohtawa, Yusuke Hishinuma, Eiji Takagi, Takafumi Yamada, Fumihiro Ito, Shiho Arima, Ryuji Uchida, Yong-Pil Kim, Satoshi Omura, Hiroshi Tomoda, Tohru Nagamitsu

      CHEMICAL & PHARMACEUTICAL BULLETIN64 ( 9 ) 1370 - 1377   9 2016

      More details

      Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:PHARMACEUTICAL SOC JAPAN  

      Cyslabdan was isolated from the culture broth of Streptoinyces sp. K04-0144 as a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus. We accomplished the synthesis of cyslabdan according to a previously reported structure. However, we subsequently found that this structure was incorrect; our analysis of natural cyslabdan showed that it possessed R stereochemistry at the C8 position, not S, as had previously been reported. Thus, we completed the protecting-group-free synthesis of the correct structure of cyslabdan, which is described herein.

      DOI: 10.1248/cpb.c16-00382

      researchmap

    • Simplifungin and Valsafungins, Antifungal Antibiotics of Fungal Origin Peer-reviewed

      Hiroyuki Ishijima, Ryuji Uchida, Masaki Ohtawa, Ariko Kondo, Kenichiro Nagai, Keisuke Shima, Kenichi Nonaka, Rokuro Masuma, Susumu Iwamoto, Hideyuki Onodera, Tohru Nagamitsu, Hiroshi Tomoda

      JOURNAL OF ORGANIC CHEMISTRY81 ( 17 ) 7373 - 7383   9 2016

      More details

      Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

      The targets of antifungal antibiotics in clinical use are more limited than those of antibacterial antibiotics. Therefore, new antifungal antibiotics with different mechanisms of action are desired. In the course of our screening for antifungal antibiotics of microbial origins, new antifungal antibiotics, simplifungin (1) and valsafungins A (2) and B (3), were isolated from cultures of the fungal strains Simplicillium minatense FKI-4981 and Valsaceae sp. FKH-53, respectively. The structures of 1 to 3 including their absolute stereochemistries were elucidated using various spectral analyses including NMR and collision-induced dissociation (CID)-MS/MS as well as chemical approaches including modifications to the Mosher's method. They were structurally related to myriocin. They inhibited the growth of yeast-like and zygomycetous fungi with MICs ranging between 0.125 and 8.0 mu g/mL. An examination of their mechanisms of action by the newly established assay using LC-MS revealed that 1 and 2 inhibited serine palmitoyltransferase activity, which is involved in sphingolipid biosynthesis, with IC50 values of 224 and 24 nM, respectively.

      DOI: 10.1021/acs.joc.6b00952

      researchmap

    • New Pyripyropene A Derivatives, Highly SOAT2-Selective Inhibitors, Improve Hypercholesterolemia and Atherosclerosis in Atherogenic Mouse Models Peer-reviewed

      Taichi Ohshiro, Masaki Ohtawa, Tohru Nagamitsu, Daisuke Matsuda, Hiroaki Yagyu, Matthew A. Davis, Lawrence L. Rudel, Shun Ishibashi, Hiroshi Tomoda

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS355 ( 2 ) 297 - +   11 2015

      More details

      Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS  

      Sterol O-acyltransferase 2 (SOAT2; also known as ACAT2) is considered as a new therapeutic target for the treatment or prevention of hypercholesterolemia and atherosclerosis. Fungal pyripyropene A (PPPA: 1,7,11-triacyl type), the first SOAT2-selective inhibitor, proved orally active in vivo using atherogenic mouse models. The purpose of the present study was to demonstrate that the PPPA derivatives (PRDs) prove more effective in the mouse models than PPPA. Among 196 semisynthetic PPPA derivatives, potent, SOAT2-selective, and stable PRDs were selected. In vivo antiatherosclerotic activity of selected PRDs was tested in apolipoprotein E knockout (Apoe(-/-)) mice or low-density lipoprotein receptor knockout (Ldlr(-/-)) mice fed a cholesterol-enriched diet (0.2% cholesterol and 21% fat) for 12 weeks. During the PRD treatments, no detrimental side effects were observed. Among three PRDs, Apoe(-/-) mice treated with PRD125 (1-,11-O-benzylidene type) at 1 mg/kg/day had significantly lower total plasma cholesterol concentration by 57.9 +/- 9.3%; further, the ratio of cholesteryl oleate to cholesteryl linoleate in low-density lipoprotein was lower by 55.6 +/- 7.5%, respectively. The hepatic cholesteryl ester levels and SOAT2 activity in the small intestines and livers of the PRD-treated mice were selectively lowered. The atherosclerotic lesion areas in the aortae of PRD125-treated mice were significantly lower at 62.2 +/- 13.1%, respectively. Furthermore, both PRDs were also orally active in atherogenic Ldlr(-/-) mice. Among the PRDs tested, PRD125 was the most potent in both mouse models. These results suggest that SOAT2-selective inhibitors such as PRD125 have a high potential as poststatin agents for treatment and/or prevention in patients with atherosclerosis and hypercholesterolemia.

      DOI: 10.1124/jpet.115.227348

      researchmap

    • Design, synthesis, and biological evaluation of air-stable nafuredin-gamma analogs as complex I inhibitors Peer-reviewed

      Masaki Ohtawa, Mari Matsunaga, Keiko Fukunaga, Risa Shimizu, Eri Shimizu, Shiho Arima, Junko Ohmori, Kiyoshi Kita, Kazuro Shiomi, Satoshi Omura, Tohru Nagamitsu

      BIOORGANIC & MEDICINAL CHEMISTRY23 ( 5 ) 932 - 943   3 2015

      More details

      Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

      Nafuredin-gamma (2), converted from nafuredin (1) under mild basic conditions, demonstrates potent and selective inhibitory activity against helminth complex I. However, 2 is unstable in air because the conjugated dienes are oxygen-labile. To address this, we designed and synthesized air-stable nafuredin-gamma analogs. Although the complex I inhibitory activities of all the new nafuredin-gamma analogs were lower than that of 2, all were in the high nM range (IC50: 300-820 nM). (C) 2015 Elsevier Ltd. All rights reserved.

      DOI: 10.1016/j.bmc.2015.01.030

      researchmap

    • Synthesis and biological activity of 5-(4-methoxyphenyl)-oxazole derivatives Peer-reviewed

      Daisuke Yamamuro, Ryuji Uchida, Masaki Ohtawa, Shiho Arima, Yushi Futamura, Masumi Katane, Hiroshi Homma, Tohru Nagamitsu, Hiroyuki Osada, Hiroshi Tomoda

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS25 ( 2 ) 313 - 316   1 2015

      More details

      Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

      5-(4'-Methoxyphenyl)-oxazole (MPO), originally reported as a synthetic compound, was isolated from fungal culture broth as an inhibitor of hatch and growth of Caenorhabditis elegans. Nineteen MPO derivatives were chemically synthesized, but showed no effect on C. elegans hatch and growth. These findings strongly suggested that the whole structure of MPO is essential for anti-C. elegans activity. (C) 2014 Elsevier Ltd. All rights reserved.

      DOI: 10.1016/j.bmcl.2014.11.042

      researchmap

    • In vitro metabolism of pyripyropene A and ACAT inhibitory activity of its metabolites Peer-reviewed

      Daisuke Matsuda, Taichi Ohshiro, Masaki Ohtawa, Hiroyuki Yamazaki, Tohru Nagamitsu, Hiroshi Tomoda

      JOURNAL OF ANTIBIOTICS68 ( 1 ) 27 - 34   1 2015

      More details

      Language:English   Publishing type:Research paper (scientific journal)   Publisher:JAPAN ANTIBIOTICS RESEARCH ASSOC  

      Pyripyropene A (PPPA, 1) of fungal origin, a selective inhibitor of acyl-CoA: cholesterol acyltransferase 2 (ACAT2), proved orally active in atherogenic mouse models. The in vitro metabolites of 1 in liver microsomes and plasma of human, rabbit, rat and mouse were analyzed by ultra fast liquid chromatography and liquid chromatography/tandem mass spectrometry. In the liver microsomes from all species, successive hydrolysis occurred at the 1-O-acetyl residue, then at the 11-O-acetyl residue of 1, while the 7-O-acetyl residue was resistant to hydrolysis. Furthermore, dehydrogenation of the newly generated 11-alcoholic hydroxyl residue occurred in human and mouse-liver microsomes, while oxidation of the pyridine ring occurred in human and rabbit liver microsomes. On the other hand, hydrolysis of the 7-O-acetyl residue proceeded only in the mouse plasma. These data indicated that the in vitro metabolic profiles of 1 have subtle differences among animal species. All of the PPPA metabolites observed in liver microsomes and plasma markedly decreased ACAT2 inhibitory activity. These findings will help us to synthesize new PPPA derivatives more effective in in vivo study than 1.

      DOI: 10.1038/ja.2014.91

      researchmap

    • Design and synthesis of A-ring truncated pyripyropene A analogs as potent ACAT2 selective inhibitors Peer-reviewed

      大多和正樹, 大村 智, 供田 洋, 長光 亨

      Medchem News24 ( 3 ) 25 - 31   1 8 2014

      More details

      Language:Japanese   Publishing type:Research paper (scientific journal)  

      DOI: 10.5059/yukigoseikyokaishi.71.830

      researchmap

    • Regioselective Mono-Deprotection of Di-tert-butylsilylene Acetal Derived from 1,3-Diol with Ammonium Fluoride Peer-reviewed

      Masaki Ohtawa, Hiroshi Tomoda, Tohru Nagamitsu

      BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN87 ( 1 ) 113 - 118   1 2014

      More details

      Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:CHEMICAL SOC JAPAN  

      Here we report a novel and efficient method for the regioselective mono-deprotection of di-tert-butylsilylene acetals derived from 1,3-diols consisting of primary and secondary alcohols. The ammonium fluoride-mediated reactions of pyripyropene A derivative, thymidine and uridine derivatives, methyl beta-D-glucofuranoside, and pyranoside derivatives each gave the corresponding primary alcohol with high regioselectivity.

      DOI: 10.1246/bcsj.20130237

      researchmap

    • Structure-Activity Relationship Study and Total Synthesis of Pyripyropene A as a Potent ACAT2-Selective Inhibitor Peer-reviewed

      Masaki Ohtawa, Satoshi Omura, Hiroshi Tomoda, Tohru Nagamitsu

      JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN71 ( 8 ) 830 - 843   8 2013

      More details

      Authorship:Lead author   Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:SOC SYNTHETIC ORGANIC CHEM JPN  

      Fungal pyripyropene A (PPPA, 1), consisting of pyridine, a-pyrone, and sesquiterpene moieties, is the only potent and selective inhibitor of acyl-CoA: cholesterol acyl transferase 2 (ACAT2) isozyme. In an effort to develop potent and selective inhibitors toward ACAT2, structure-activity relationship studies were carried out using derivatives based on 1. We have successfully developed novel 1,11-O-o-substituted benzylidene-7-p-cyanobenzoyloxy PPPA derivatives that exhibit significantly more potent ACAT2 inhibitory activity and much higher isozyme selectivity than 1.
      Furthermore, we have achieved a stereocontrolled total synthesis of 1. Key features of the synthetic strategy included an intramolecular Ti (III)-mediated radical cyclization for construction of the A-ring, stereoselective beta-epoxide formation/Peterson olefination for preparation of the functional groups on the B-ring, and stereoselective intramolecular cyclization through hetero-Michael addition for C-ring formation. Extension of this chemistry to the synthesis of an A-ring truncated PPPA analog for structure-activity relationship studies has also been achieved.

      DOI: 10.5059/yukigoseikyokaishi.71.830

      researchmap

    • Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA: cholesterol acyltransferase 2 (ACAT2) inhibitors: Part 3 Peer-reviewed

      Masaki Ohtawa, Hiroyuki Yamazaki, Satoshi Ohte, Daisuke Matsuda, Taichi Ohshiro, Lawrence L. Rudel, Satoshi Omura, Hiroshi Tomoda, Tohru Nagamitsu

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS23 ( 13 ) 3798 - 3801   7 2013

      More details

      Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

      In an effort to develop potent and selective inhibitors toward ACAT2, structure-activity relationship studies were carried out using derivatives based on pyripyropene A (PPPA, 1). In particular, we investigated the possibility of introducing appropriate 1,11-O-benzylidene and 7-O-substituted benzoyl moieties into PPPA (1). The new o-substituted benzylidene derivatives showed higher selectivity for ACAT2 than PPPA (1). Among them, 1,11-O-o-methylbenzylidene-7-O-p-cyanobenzoyl PPPA derivative 7q and 1,11-O-o, o-dimethylbenzylidene-7-O-p-cyanobenzoyl PPPA derivative 7z proved to be potent ACAT2 inhibitors with unprecedented high isozyme selectivity. (C) 2013 Elsevier Ltd. All rights reserved.

      DOI: 10.1016/j.bmcl.2013.04.075

      researchmap

    • Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: Part 2 Peer-reviewed

      Masaki Ohtawa, Hiroyuki Yamazaki, Daisuke Matsuda, Taichi Ohshiro, Lawrence L. Rudel, Satoshi Omura, Hiroshi Tomoda, Tohru Nagamitsu

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS23 ( 9 ) 2659 - 2662   5 2013

      More details

      Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

      Synthesis and structure-activity relationships of 7-O-p-cyanobenzoyl pyripyropene A derivatives with modification at C1 and 11 are described. Regioselective mono-deprotection of di-tert-butylsilylene acetal was critical in their synthesis. (C) 2013 Elsevier Ltd. All rights reserved.

      DOI: 10.1016/j.bmcl.2013.02.088

      researchmap

    • Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: Part 1 Peer-reviewed

      Masaki Ohtawa, Hiroyuki Yamazaki, Satoshi Ohte, Daisuke Matsuda, Taichi Ohshiro, Lawrence L. Rudel, Satoshi Omura, Hiroshi Tomoda, Tohru Nagamitsu

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS23 ( 5 ) 1285 - 1287   3 2013

      More details

      Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

      In an effort to develop potent and selective inhibitors toward ACAT2, structure-activity relationship studies were carried out using derivatives based on pyripyropene A (PPPA, 1). We have successfully developed novel PPPA derivatives with a 7-O-substituted benzoyl substituent that significantly exhibit more potent ACAT2 inhibitory activity and higher ACAT2 isozyme selectivity than 1. (c) 2013 Elsevier Ltd. All rights reserved.

      DOI: 10.1016/j.bmcl.2012.12.099

      researchmap

    • In vivo Efficacy of PRD017, a New Pyripyropene a Derivative and Highly Potent SOAT2-Selective Inhibitor, in Apolipoprotein E KO Mice Peer-reviewed

      Taichi Ohshiro, Masaki Ohtawa, Daisuke Matsuda, Tohru Nagamitsu, Hiroaki Yagyu, Jun-ichi Osuga, Lawrence L. Rudel, Shun Ishibashi, Hiroshi Tomoda

      CIRCULATION126 ( 21 )   11 2012

      More details

      Language:English   Publishing type:Research paper (international conference proceedings)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

      researchmap

    • ChemInform Abstract: Stereoselective Total Synthesis of Atpenins A4 and B, Harzianopyridone, and NBRI23477 B. Peer-reviewed

      Masaki Ohtawa, Kouhei Sugiyama, Tohru Hiura, Shujiro Izawa, Kazuro Shiomi, Satoshi Omura, Tohru Nagamitsu

      ChemInform43 ( 47 ) no - no   10 2012

      More details

      Publishing type:Research paper (scientific journal)   Publisher:Wiley-Blackwell  

      DOI: 10.1002/chin.201247212

      researchmap

    • Stereoselective Total Synthesis of Atpenins A4 and B, Harzianopyridone, and NBRI23477 B Peer-reviewed

      Masaki Ohtawa, Kouhei Sugiyama, Tohru Hiura, Shujiro Izawa, Kazuro Shiomi, Satoshi Omura, Tohru Nagamitsu

      CHEMICAL & PHARMACEUTICAL BULLETIN60 ( 7 ) 898 - 906   7 2012

      More details

      Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:PHARMACEUTICAL SOC JAPAN  

      The stereoselective total synthesis of atpenins A4 (2) and B (3), harzianopyridone (4), and NBRI23477 B (5) have been developed using a convergent approach involving the coupling reaction of a common iodopyridine with an aldehyde corresponding to the appropriate side chain of the desired compound. Furthermore, the absolute configurations of atpenin B (3), harzianopyridone (4), and NBRI23477 B (5) have been unambiguously determined.

      DOI: 10.1248/cpb.c12-00266

      researchmap

    • Potentiation of Bleomycin in Jurkat Cells by Fungal Pycnidione Peer-reviewed

      Mayumi Kaneko, Daisuke Matsuda, Masaki Ohtawa, Takashi Fukuda, Tohru Nagamitsu, Takao Yamori, Hiroshi Tomoda

      BIOLOGICAL & PHARMACEUTICAL BULLETIN35 ( 1 ) 18 - 28   1 2012

      More details

      Language:English   Publishing type:Research paper (scientific journal)   Publisher:PHARMACEUTICAL SOC JAPAN  

      Most cancer cells have mutations in genes at the Cl checkpoint and repair DNA only in the 62 phase; therefore, the 62 checkpoint is a potential target to develop novel therapy. In the course of screening, a known compound, pycnidione, was isolated from the fungal culture broth of Gloeotinia sp. FKI-3416. Pycnidione irreversibly abrogated bleomycin-induced G2 arrest in Jurkat cells and synergically potentiated the cytotoxicity of bleomycin. To elucidate the mechanism of action, the effect of pycnidione on the signal transduction of the 62 checkpoint was analyzed, showing that the increased phospho-cyclin dependent kinase-1 (CDK1) level caused by bleomycin was abrogated in the presence of pycnidione, indicating that cells did not arrest at the 62 phase. Moreover, under these conditions, Chk1 and Chk2 levels were markedly down-regulated. Thus, we concluded that pycnidione abrogated bleomycin-induced 62 arrest by decreasing Chk1 and Chk2.

      DOI: 10.1248/bpb.35.18

      researchmap

    • Total synthesis of pyripyropene A Peer-reviewed

      Atsuki Odani, Kaoru Ishihara, Masaki Ohtawa, Hiroshi Tomoda, Satoshi Omura, Tohru Nagamitsu

      TETRAHEDRON67 ( 42 ) 8195 - 8203   10 2011

      More details

      Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

      The total synthesis of pyripyropene A, a potent ACAT2 inhibitor with high isozyme selectivity, was completed. Key features of the synthetic strategy include Ti(III)-mediated radical cyclization and Peterson olefination for the construction of the AB ring segment and stereoselective dihydro-gamma-pyrone formation (C-ring). The total synthesis provided pyripyropene A in 5.3% overall yield over 17 steps. (C) 2011 Published by Elsevier Ltd.

      DOI: 10.1016/j.tet.2011.06.084

      researchmap

    • ChemInform Abstract: Enantioselective Total Synthesis of Atpenin A5. Peer-reviewed

      Masaki Ohtawa, Satoru Ogihara, Kouhei Sugiyama, Kazuro Shiomi, Yoshihiro Harigaya, Tohru Nagamitsu, Satoshi Omura

      ChemInform40 ( 45 )   10 11 2009

      More details

      Publishing type:Research paper (scientific journal)   Publisher:Wiley-Blackwell  

      DOI: 10.1002/chin.200945203

      researchmap

    • Enantioselective total synthesis of atpenin A5 Peer-reviewed

      Masaki Ohtawa, Satoru Ogihara, Kouhei Sugiyama, Kazuro Shiomi, Yoshihiro Harigaya, Tohru Nagamitsu, Satoshi Omura

      JOURNAL OF ANTIBIOTICS62 ( 6 ) 289 - 294   6 2009

      More details

      Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:JAPAN ANTIBIOTICS RESEARCH ASSOC  

      Enantioselective total synthesis of atpenin A5, a potent mitochondrial complex II (succinate-ubiquinone oxidoreductase) inhibitor, has been achieved by a convergent approach through a coupling reaction between 5-iodo-2,3,4,6-tetraalkoxypyridine and a side-chain aldehyde. The two key segments were synthesized through ortho-metalation/boronation with (MeO)(3)B/oxidation with mCPBA, ortho-iodination, halogen dance reaction, Sharpless epoxidation and regioselective epoxide-opening reaction. This synthetic study resulted in the revision of the earlier reported (1)H-NMR data of the natural atpenin A5 and the confirmation of the stereochemical assignment. The Journal of Antibiotics (2009) 62, 289-294; doi:10.1038/ja.2009.29; published online 17 April 2009

      DOI: 10.1038/ja.2009.29

      researchmap

    • 9-(2-C-cyano-2-deoxy-β-D-arabino-pentofuranosyl)guanine, a potential antitumor agent against B-lymphoma infected with Kaposi’s sarcoma-associated herpesvirus International journal

      Ichikawa S, Ohtawa M, Teishikata Y, Yamada K, Fujimuro M, Yokosawa H, Matsuda A

      Nucleic Acids Sympo ser53 ( 1 ) 95 - 96   1 6 2009

      More details

      Language:Japanese   Publishing type:Research paper (scientific journal)  

      Several 9-(2-C-cyano-2-deoxy-l-beta-D-arabino-pentofuranosyl)purine derivatives were tested against Kaposi's sarcoma-associated herpesvirus (KSHV)-infected primary effusion lymphoma (PEL) cells. The guanine derivative (2, CNDAG) as well as the 2-amino-6-substituted-purine derivatives 3, 4 and 5 inhibited KSHV-positive cell growth but showed no cytotoxicity against KSHV-negative cells at >15 muM concentrations. Therefore, it was found that compounds 2, 3, 4 and 5 showed selective cytotoxicity against PEL cells infected with KSHV.

      DOI: 10.1093/nass/nrp048

      PubMed

      researchmap

    • Selectivity of pyripyropene derivatives in inhibition toward acyl-CoA : cholesterol acyltransferase 2 isozyme Peer-reviewed

      Taichi Ohshiro, Satoshi Ohte, Daisuke Matsuda, Masaki Ohtawa, Tohru Nagamitsu, Toshiaki Sunazuka, Yoshihiro Harigaya, Lawrence L. Rudel, Satoshi Omura, Hiroshi Tomoda

      JOURNAL OF ANTIBIOTICS61 ( 8 ) 503 - 508   8 2008

      More details

      Language:English   Publishing type:Research paper (scientific journal)   Publisher:JAPAN ANTIBIOTICS RESEARCH ASSOC  

      Selectivity of 96 semisynthetic derivatives prepared from fungal pyripyropene A, originally isolated as a potent inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT), toward ACAT1 and ACAT2 isozymes was investigated in the cell-based assay using ACAT1- and ACAT2-expressing CHO cells. Eighteen derivatives including PR-71 (7-O-isocaproyl derivative) showed much more potent ACAT2 inhibition (IC(50): 6.0 to 62 nM) than pyripyropene A (IC(50): 70 nM). Among them, however, natural pyripyropene A showed the highest selectivity toward ACAT2 with a selectivity index (SI) of &gt;1000, followed by PR-71 (SI, 667).

      DOI: 10.1038/ja.2008.67

      researchmap

    • The total synthesis and biological evaluation of nafuredin-gamma and its analogues Peer-reviewed

      Tohru Nagamitsu, Daisuke Takano, Miyuki Seki, Shiho Arima, Masaki Ohtawa, Kazuro Shiomi, Yoshihiro Harigaya, Satoshi Omura

      TETRAHEDRON64 ( 35 ) 8117 - 8127   8 2008

      More details

      Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

      Nafuredin (1) is converted to nafuredin-gamma (2) under mild basic conditions and both compounds exhibit the same inhibitory activity and selectivity against NADH-fumarate reductase (complex 1). The total synthesis of 2 was achieved by a convergent approach using Stille coupling. The structural elements required for inhibitory activity against NADH-fumarate reductase (complex I) were then investigated by evaluation of nafuredin-gamma (2) and its structural analogues. (C) 2008 Elsevier Ltd. All rights reserved.

      DOI: 10.1016/j.tet.2008.06.066

      researchmap

    • 9-(2-C-cyano-2-deoxy-beta-(D)-arabino-pentofuranosyl)guanine, a potential antitumor agent against B-lymphoma infected with Kaposi's sarcoma-associated herpesvirus Peer-reviewed

      Masaki Ohtawa, Satoshi Ichikawa, Yasuhiro Teishikata, Masahiro Fujimuro, Hideyoshi Yokosawa, Akira Matsuda

      JOURNAL OF MEDICINAL CHEMISTRY50 ( 9 ) 2007 - 2010   5 2007

      More details

      Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

      Several 9-(2-C-cyano-2-deoxy-l-beta-D-arabino-pentofuranosyl)purine derivatives were tested against Kaposi's sarcoma-associated herpesvirus (KSHV)-infected primary effusion lymphoma (PEL) cells. The guanine derivative (3, CNDAG), as well as the 2-amino-6-substituted-purine derivatives 4, 5, and 6, exhibited cell growth inhibitory activity against KSHV-infected cells, but showed no cytotoxicity against KSHV-negative cells at &gt; 15 mu M concentrations. Therefore, it was found that compounds 3, 4, 5, and 6 showed selective cytotoxicity against PEL cells infected with KSHV.

      DOI: 10.1021/jm070032y

      researchmap

    ▼display all

    Misc.

    • Total syntheses of CJ-16,170 and 2-epi-CJ-16,169 via the regioselective iodocyclization

      李大葵, 鴇崎拓也, 長井啓祐, 有馬志保, 大多和正樹, 長光亨

      複素環化学討論会講演要旨集50th   2021

      More details

    • 位置選択的なヨード環化反応を利用したCJ-16,170および2-epi-CJ-16,169の全合成

      李大葵, 鴇崎拓也, 長井啓祐, 有馬志保, 大多和正樹, 長光亨

      日本薬学会関東支部大会講演要旨集65th (CD-ROM)   2021

      More details

    • 4-epi-Atpenin A5の全合成

      李大葵, 大多和正樹, 長光亨

      反応と合成の進歩シンポジウム講演要旨集45th   2019

      More details

    • 4’-epi-Atpenin A5の合成研究

      李大葵, 大多和正樹, 桑山裕衣, 長光亨

      日本薬学会年会要旨集(CD-ROM)138th   2018

      More details

    • 4′-epi-Atpenin A5の合成研究

      李大葵, 大多和正樹, 桑山裕衣, 長光亨

      日本薬学会関東支部大会講演要旨集62nd   2018

      More details

    • Amphotericin B活性増強作用を有するsimpotentinの全合成と絶対立体配置の決定

      大多和正樹, 清水恵理, 齋藤淳, 李大葵, 近藤あり子, 八木瑛穂, 小林啓介, 内田龍児, 供田洋, 長光亨

      反応と合成の進歩シンポジウム講演要旨集44th   2018

      More details

    • FOP治療薬の創製を目指したscopranone Aの全合成ならびに誘導体合成

      李大葵, 渡邊望, 大多和正樹, 下山健太, 内田龍児, 供田洋, 長光亨

      日本薬学会年会要旨集(CD-ROM)137th   2017

      More details

    • FOP治療薬の創製を目指したscopranone Aの全合成ならびに誘導体合成

      李大葵, 渡邊望, 大多和正樹, 下山健太, 内田龍児, 供田洋, 長光亨

      日本薬学会関東支部大会講演要旨集60th (CD-ROM)   2016

      More details

    • 真菌が生産する新規抗真菌活性物質simplifunginおよびvalsafungin類に関する研究

      石島広之, 内田龍児, 大多和正樹, 近藤あり子, 長井賢一郎, 島圭介, 野中健一, 増間緑郎, 岩本晋, 小野寺秀幸, 長光亨, 供田洋

      天然有機化合物討論会講演要旨集(Web)58th   2016

      More details

    ▼display all

    Presentations

    • 天然物合成を基盤とする幅広い有機合成化学 Invited

      大多和正樹

      2024年度有機合成化学協会北海道支部若手研究者のための有機化学札幌セミナー  31 10 2024 

      More details

    • 核酸化学から始まった有機合成化学 Invited

      第2回核酸化学を基盤とする医薬品化学シンポジウム  7 9 2024 

      More details

    • Shodoamide C の全合成と絶対立体配置の決定

      植木 翔梧, 八木 瑛穂, 平田 晃大, 供田 洋, 内田 龍児, 長光 亨, 大多和 正樹

      第66回天然有機化合物討論会  4 9 2024 

      More details

      Event date: 4 9 2024 - 6 9 2024

      researchmap

    • Lamellolactone 類の全合成

      布施 侑叶, 長光 亨, 大多和 正樹

      日本薬学会第144年会  31 3 2024 

      More details

    • Gibberellin 類の合成研究

      中平 善幸, 井上 波音, 安成 範顕, 田村 歩夢, 長光 亨, 大多和 正樹

      日本薬学会第144年会  30 3 2024 

      More details

    • Shodoamide C の全合成研究

      植木 翔梧, 平田 晃大, 大城 太一, 供田 洋, 内田 龍児, 長光 亨, 大多和 正樹

      日本薬学会第144年会  29 3 2024 

      More details

    • 天然物合成を指向したブテノリドラジカルを介する反応開発研究

      小田 みづき, 内藤 真帆, 勅使川原, 壮平, 長光 亨, 大多和 正樹

      日本薬学会第144年会  29 3 2024 

      More details

    • Concise syntheses of (–)-habiterpenol and (+)-2,3-epi-habiterpenol via MHAT-initiated redox radical cyclization of alkenylsilane

      Haruki Taguchi, Mayuko Kawaguchi, Tohru Nagamitsu, Masaki Ohtawa

      The 15th International Kyoto Conference on New Aspects of Organic Chemistry (IKCOC-15)  21 11 2023 

      More details

      Event date: 20 11 2023 - 23 11 2023

      Language:English   Presentation type:Poster presentation  

      researchmap

    • Shodoamide C の合成研究

      植木 翔梧, 平田 晃大, 岩堀 雅大, 大城 太一, 供田 洋, 内田 龍児, 長光 亨, 大多和 正樹

      第67回日本薬学会関東支部大会  16 9 2023 

      More details

    • Concise total syntheses of (–)-11-O-debenzoyltashironin and (–)-bilobalide Invited

      Masaki Ohtawa

      International Congress on Pure & Applied Chemistry (ICPAC) Bali 2023  15 9 2023 

      More details

      Presentation type:Oral presentation (invited, special)  

      researchmap

    • アルケニルシランに対する MHAT 駆動型レドックス環化反応を鍵とする habiterpenol および 2,3-epi-habiterpenol の全合成

      田口 遥規, 川口 真由子, 有馬 志保, 長光 亨, 大多和 正樹

      第122回有機合成シンポジウム  19 7 2023 

      More details

    • 天然物合成を指向したブテノリドラジカルを介する反応開発研究

      小田 みづき, 内藤 真帆, 勅使川原, 壮平, 長光 亨, 大多和 正樹

      第21回次世代を担う有機化学シンポジウム  26 5 2023 

      More details

      Event date: 26 5 2023 - 27 5 2023

      researchmap

    • Shodoamide C の合成研究

      平田 晃大, 岩堀 雅大, 大城 太一, 供田 洋, 内田 龍児, 長光 亨, 大多和 正樹

      日本薬学会第143年会  26 3 2023 

      More details

      Presentation type:Poster presentation  

      researchmap

    • 神経栄養保護作用を有するかご型テルペノイドの全合成 Invited

      大多和 正樹

      名古屋大学大学院第156回創薬科学セミナー/GTRセミナー  7 12 2022 

      More details

    • アルケニルシランに対する MHAT 駆動形レドックス環化反応を鍵とする habiterpenol および 2,3-epi-habiterpenol の全合成

      田口 遥規, 川口 真由子, 有馬 志保, 長光 亨, 大多和 正樹

      第12回北里化学シンポジウム  3 12 2022 

      More details

    • ミロガバリンの合成研究

      植木 翔悟, 野沢 朋加, 長光 亨, 大多和 正樹

      第12回北里化学シンポジウム  3 12 2022 

      More details

    • ブテノリドラジカルを用いた反応開発研究

      小田 みづき, 内藤 真帆, 勅使川原, 壮平, 長光 亨, 大多和 正樹

      第12回北里化学シンポジウム  3 12 2022 

      More details

    • ブテノリドラジカルのダイマー化を鍵とする biatractylolide の全合成研究

      川口 真由子, 長光 亨, 大多和 正樹

      第12回北里化学シンポジウム  3 12 2022 

      More details

    • Gibberellin A1 及び A3 の合成研究

      安成 範顕, 田村 歩夢, 中平 善幸, 長光 亨, 大多和 正樹

      第12回北里化学シンポジウム  3 12 2022 

      More details

    • Shodoamide C の合成研究

      平田 晃大, 岩堀 雅大, 大城 太一, 供田 洋, 内田 龍児, 長光 亨, 大多和 正樹

      第12回北里化学シンポジウム  3 12 2022 

      More details

    • Gibberellin A1 及び A3 の合成研究

      安成 範顕, 田村 歩夢, 中平 善幸, 長光 亨, 大多和 正樹

      第66回日本薬学会関東支部大会  17 9 2022 

      More details

    • ビニルシランに対する MHAT 駆動形レドックス環化反応を鍵とする habiterpenol および 2,3-epi-habiterpenol の全合成

      大多和 正樹, 田口 遥規, 川口 真由子, 有馬 志保, 長光 亨

      第64回天然有機化合物討論会  7 9 2022 

      More details

    • Habiterpenol および2,3-epi-habiterpenolの第二世代全合成

      田口 遥規, 川口 真由子, 有馬 志保, 長光 亨, 大多和 正樹

      日本薬学会第142年会  28 3 2022 

      More details

    • ブテノリドラジカルを用いた反応開発研究と天然物合成への応用

      勅使川原, 壮平, 山口 茉里絵, 長光 亨, 大多和 正樹

      日本薬学会第142年会  26 3 2022 

      More details

    • 特徴的な生物活性を有する天然有機化合物を中心とした創薬研究、全合成および反応開発研究 Invited

      大多和 正樹

      第46回白金シンポジウム  14 12 2021 

      More details

    • 位置選択的なヨード環化反応を利用した CJ-16,170 及び 2-epi-CJ-16,169 の全合成

      李 大葵, 鴇崎 拓也, 長井 啓祐, 有馬 志保, 大多和 正樹, 長光 亨

      第50回複素環化学討論会  7 10 2021 

      More details

    • 位置選択的なヨード環化反応を利用した CJ-16,170 及び 2-epi-CJ-16,169 の全合成

      李 大葵, 鴇崎 拓也, 長井 啓祐, 有馬 志保, 大多和 正樹, 長光 亨

      第63回天然有機化合物討論会  15 9 2021 

      More details

    • ブテノリドラジカルを用いた反応開発研究と天然物合成への応用

      勅使川原, 壮平, 山口 茉里絵, 長光 亨, 大多和 正樹

      第65回日本薬学会関東支部大会  11 9 2021 

      More details

    • 位置選択的なヨード環化反応を利用した CJ-16,170 及び 2-epi-CJ-16,169 の全合成

      李 大葵, 鴇崎 拓也, 長井 啓祐, 有馬 志保, 大多和 正樹, 長光 亨

      第65回日本薬学会関東支部大会  11 9 2021 

      More details

    • Habiterpenol の第二世代全合成

      田口 遥規, 川口 真由子, 有馬 志保, 長光 亨, 大多和 正樹

      第65回日本薬学会関東支部大会  11 9 2021 

      More details

    • 特徴的な生物活性を有する天然有機化合物を中心とした創薬研究、全合成および反応開発研究 Invited

      大多和 正樹

      第65回日本薬学会関東支部大会  11 9 2021 

      More details

    • 天然物から広がる有機合成化学 〜全合成から創薬まで〜 Invited

      大多和 正樹

      第8回慶應有機化学若手シンポジウム  8 5 2021 

      More details

    • 構造の複雑な天然物の効率的な全合成経路の構築を目指して Invited

      大多和 正樹

      日本薬学会第141年会 シンポジウム「有機合成の若い力」  29 3 2021 

      More details

    • ホモプロパルギルアルコールの新規ラクトン化反応の開発研究とスピロノラクトンの短工程合成への応用

      平田 晃大, 山根 大地, 田中 晴菜, 田村 裕実子, 長光 亨, 大多和 正樹

      日本薬学会第141年会  28 3 2021 

      More details

    • 位置選択的なヨード環化反応を利用した CJ-16,170 及び 2-epi-CJ-16,169 の全合成

      李 大葵, 鴇﨑 拓也, 長井 啓祐, 有馬 志保, 大多和 正樹, 長光 亨

      日本薬学会第141年会  28 3 2021 

      More details

    • Gibberellin A1 及び A3 の全合成研究

      田村 歩夢, 安成 範顕, 長光 亨, 大多和 正樹

      日本薬学会第141年会  27 3 2021 

      More details

    • Habiterpenolの第二世代合成研究

      田口 遥規, 長光 亨, 大多和 正樹

      日本薬学会第141年会  27 3 2021 

      More details

    • Amphotericin B活性増強作用を有するsimpotentinの全合成と絶対立体配置の決定

      大多和正樹, 李 大葵, 清水恵里, 齊藤 惇, 近藤あり子, 八木瑛穂, 内田龍児, 供田 洋, 長光 亨

      日本薬学会第140年会  26 3 2020  日本薬学会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:京都  

      researchmap

    • 骨分化阻害物質scopranoneとアミノ酸との反応

      金田幸歩, 大手聡, 李大葵, 大多和正樹, 内田龍児, 長光亨, 供田洋

      日本薬学会第140年会  26 3 2020  日本薬学会

      More details

      Language:Japanese   Presentation type:Oral presentation (general)  

      Venue:京都  

      researchmap

    • ケテン中間体を経由するホモプロパルギルアルコールの新規ラクトン化反応の開発研究

      山根大地, 田中晴菜, 高橋大地, Ryan Shenvi, 長光亨, 大多和正樹

      日本薬学会第140年会  26 3 2020  日本薬学会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:京都  

      researchmap

    • ケテン中間体を経由する新規ラクトン化反応の開発研究

      山根大地, 田中晴菜, 高橋大地, Ryan A. Shenvi, 長光 亨, 大多和正樹

      第11回北里化学シンポジウム  21 12 2019  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • 4-epi-Atpenin A5の全合成

      李 大葵, 大多和正樹, 長光 亨

      第11回北里化学シンポジウム  21 12 2019  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • Ukulactoneの合成研究

      田村歩夢, 吉永理紗, 長光 亨, 大多和正樹

      第11回北里化学シンポジウム  21 12 2019  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • Habiterpenolの第2世代合成研究

      田口遥規, 内田龍児, 供田 洋, 長光 亨, 大多和正樹

      第11回北里化学シンポジウム  21 12 2019  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • ブテノリドラジカルを用いた反応開発研究と天然物合成への応用

      勅使川原荘平, 小林 匠, 長光 亨, 大多和正樹

      第11回北里化学シンポジウム  21 12 2019  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • (-)-11-O-Debenzoyltashironin及び(-)-bilobalideの全合成

      大多和正樹, Shenvi Ryan A

      第11回北里化学シンポジウム  21 12 2019  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • ブテノリドを巧に利用する有機合成化学

      大多和正樹, 長光 亨

      第43回白金シンポジウム  17 12 2019  北里大学薬学部

      More details

      Language:Japanese   Presentation type:Symposium, workshop panel (public)  

      Venue:東京  

      researchmap

    • 4-epi-Atpenin A5の全合成

      李 大葵, 大多和正樹, 長光 亨

      第45回反応と合成の進歩シンポジウム  29 10 2019 

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:岡山  

      researchmap

    • ケテン中間体を経由するホモプロパルギルアルコールの新規ラクトン化反応の開発研究

      山根 大地, 田中 晴菜, 高橋 大地, Ryan Shenvi, 長光 亨, 大多和 正樹

      第63回日本薬学会関東支部大会  14 9 2019 

      More details

      Language:Japanese   Presentation type:Poster presentation  

      researchmap

    • 11-Step asymmetric synthesis of (–)-bilobalide

      大多和正樹, Baker Meghan, Demoret Robert, Shenvi Ryan

      第61回天然有機化合物討論会  12 9 2019  日本化学会,日本薬学会,日本農芸化学会

      More details

      Language:Japanese   Presentation type:Oral presentation (general)  

      Venue:広島  

      researchmap

    • Eleven-step synthesis of (–)-bilobalide International conference

      Demoret R M, Baker M A, Ohtawa M, Shenvi R A

      258th ACS National Meeting & Exposition  29 8 2019 

      More details

      Language:English   Presentation type:Oral presentation (general)  

      Venue:San Diego, USA  

      researchmap

    • Total synthesis and absolute configuration of simpotentin, a potentiator of amphotericin B activity International conference

      Ohtawa M, Uchuda R, Tomoda H, Nagamitsu T

      258th ACS National Meeting & Exposition  28 8 2019 

      More details

      Language:English   Presentation type:Poster presentation  

      Venue:San Diego, USA  

      researchmap

    • 11-Step catalytic asymmetric synthesis of (–)-bilobalide International conference

      Baker M A, Demoret R M, Ohtawa M, Shenvi R A

      258th ACS National Meeting & Exposition  28 8 2019 

      More details

      Language:English   Presentation type:Poster presentation  

      Venue:San Diego, USA  

      researchmap

    • SOAT2選択的阻害剤pyripyropene Aの構造簡略型誘導体の創製研究

      有馬志保, 大多和正樹, 長光 亨

      第41回白金シンポジウム  18 12 2018  北里大学薬学部

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • 効率的な合成経路の構築を指向した全合成研究とそれを可能とする反応開発研究

      大多和正樹, 長光 亨

      第41回白金シンポジウム  18 12 2018  北里大学薬学部

      More details

      Language:Japanese   Presentation type:Oral presentation (keynote)  

      Venue:東京  

      researchmap

    • Amphotericin B活性増強作用を有するsimpotentinの全合成と絶対立体配置の決定

      大多和正樹, 長光 亨

      第41回白金シンポジウム  18 12 2018  北里大学薬学部

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • simpotentinの全合成と絶対立体配置の決定

      大多和正樹, 清水恵里, 齋藤 惇, 李 大葵, 近藤あり子, 八木瑛穂, 小林啓介, 内田龍児, 供田 洋, 長光 亨

      第44回反応と合成の進歩シンポジウム  5 11 2018  日本薬学会化学系薬学部会(主催),日本薬学会生薬天然部会,日本薬学会医薬品部会(共催)

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:熊本  

      researchmap

    • SOAT2選択的阻害剤pyripyropene Aの構造簡略型誘導体の創製研究

      大多和正樹, 有馬志保, 市田直樹, 寺山富明, 大野浩直, 山碕隆也, 大城太一, 佐藤倫子, 大村 智, 供田 洋, 長光 亨

      第60回天然有機化学討論会  26 9 2018  日本化学会,日本薬学会,日本農芸化学会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:久留米  

      researchmap

    • 4’-epi-AtpeninA5の合成研究

      李 大葵, 大多和正樹, 桑山裕衣, 長光 亨

      第62回日本薬学会関東支部大会  15 9 2018  日本薬学会関東支部

      More details

      Language:Japanese   Presentation type:Oral presentation (general)  

      Venue:東京 帝京平成大学中野キャンパス  

      researchmap

    • 神経栄養・保護作用を有するセスキテルペン類の全合成研究 Invited

      大多和正樹

      第40回白金セミナー  31 5 2018  北里大学薬学部

      More details

      Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

      Venue:東京  

      researchmap

    • 神経栄養・保護作用を有するセスキテルペン類の全合成研究

      大多和正樹, Robert Demerit, Meghan Baker, Ryan Shenvi

      第16回次世代を担う有機化学シンポジウム  19 5 2018  日本薬学会化学系薬学部会

      More details

      Language:Japanese   Presentation type:Oral presentation (general)  

      Venue:大阪  

      researchmap

    • Nafuredin-γの構造活性相関研究

      有馬志保, 大多和正樹, 清水理紗, 大村 智, 長光 亨

      日本薬学会第138年会  27 3 2018  日本薬学会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:金沢  

      researchmap

    • 4-epi-AtpeninA5の合成研究

      李 大葵, 大多和正樹, 桑山裕衣, 長光 亨

      日本薬学会第138年会  26 3 2018  日本薬学会

      More details

      Language:Japanese   Presentation type:Oral presentation (general)  

      Venue:金沢  

      researchmap

    • Scopranone Aの全合成及び構造活性相関研究

      大多和正樹, 長光 亨

      第39回白金シンポジウム  19 12 2017  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • Atpenin A5の構造活性相関研究

      有馬志保, 大多和正樹, 長光 亨

      第39回白金シンポジウム  19 12 2017  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • FKI-4981Bの合成研究

      李 大葵, 青木和也, 清水恵里, 大多和正樹, 内田龍児, 供田 洋, 長光 亨

      第10回北里化学シンポジウム  16 12 2017  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:相模原  

      researchmap

    • Scopranone Aの全合成および構造活性相関研究

      李 大葵, 渡邊 望, 大多和正樹, 内田龍児, 供田 洋, 長光 亨

      第10回北里化学シンポジウム  16 12 2017  北里大学

      More details

      Language:Japanese   Presentation type:Oral presentation (general)  

      Venue:相模原  

      researchmap

    • AtpeninA5の構造活性相関研究

      有馬志保, 杉山晃平, 樋浦 徹, 矢野圭祐, 大多和正樹, 北 潔, 大村 智, 長光 亨

      第10回北里化学シンポジウム  16 12 2017  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:相模原  

      researchmap

    • FOP治療薬を指向したscopranone Aの全合成及び構造活性相関研究

      李 大葵, 大多和正樹, 内田龍児, 供田 洋, 長光 亨

      第35回メディシナルケミストリーシンポジウム  25 10 2017  日本薬学会・医薬化学部会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:名古屋  

      researchmap

    • FOP治療薬の創製を目指したscopranone Aの全合成ならびに誘導体合成

      李 大葵, 渡邊 望, 大多和正樹, 下山健太, 内田龍児, 供田 洋, 長光 亨

      日本薬学会第137年会  25 3 2017  日本薬学会

      More details

      Language:Japanese   Presentation type:Oral presentation (general)  

      Venue:仙台  

      researchmap

    • Nafuredin-γの構造簡略型誘導体の活性相関研究

      有馬志保, 大多和正樹, 長光 亨

      第37回白金シンポジウム  20 12 2016  北里大学薬学部

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • Nafuredin-γの構造活性相関研究 (2)

      大多和正樹, 有馬志保, 清水理紗, 大村 智, 長光 亨

      第34回メディシナルケミストリーシンポジウム  30 11 2016  日本薬学会医薬化学部会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:茨城  

      researchmap

    • FOP治療薬の創製を目指したscopranone Aの全合成ならびに誘導体合成

      李 大葵, 渡邊 望, 大多和正樹, 下山健太, 内田龍児, 供田 洋, 長光 亨

      第60回日本薬学会関東支部大会  17 9 2016 

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • ピロピロペン誘導体の抗動脈硬化作用

      大城太一, 大多和正樹, 長光 亨, 松田大介, 野牛宏晃, Matthew Davis, Lawrence Rudel, 石橋 俊, 供田 洋

      日本薬学会第136年会  28 3 2016  日本薬学会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:横浜  

      researchmap

    • Amphotericin B活性増強効果を有するFKI-4981Bの全合成研究

      大多和正樹, 長光 亨

      第35回白金シンポジウム  22 12 2015  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • 寄生虫選択性向上を指向した2’-置換atpenin A5誘導体の設計、合成及び活性評価

      大多和正樹, 有馬志保, 長光 亨

      第35回白金シンポジウム  22 12 2015  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • Structure-activity relationship study and total synthesis of pyripyropene A as a ACAT2-selective inhibitor

      Ohtawa M, Ohshiro T, Omura S, Tomoda H, Nagamitsu, T

      Pacifichem 2015  18 12 2015 

      More details

      Language:English   Presentation type:Poster presentation  

      Venue:ホノルル  

      researchmap

    • 寄生虫選択性向上を志向した2’-atpenin A5誘導体の合成及び活性評価

      大多和正樹, 矢野圭祐, 有馬志保, 大村 智, 長光 亨

      第33回メディシナルケミストリーシンポジウム  25 11 2015  日本薬学会医薬化学部会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:千葉県  

      researchmap

    • Structure-activity relationship study and total synthesis of pyripyropene A as a ACAT2-selective inhibitor

      Ohtawa M, Ohshiro T, Omura S, Tomoda H, Nagamitsu T

      The 13th International Kyoto Conference on New Aspects of Organic Chemistry  12 11 2015 

      More details

      Language:English   Presentation type:Poster presentation  

      Venue:京都  

      researchmap

    • Cyslabdanの全合成

      大多和正樹, 菱沼祐介, 供田 洋, 長光 亨

      第41回反応と合成の進歩シンポジウム  26 10 2015 

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:大阪  

      researchmap

    • Amphotericin B活性増強作用を有するFKI-4981Bの全合成研究

      清水恵里, 齊藤 惇, 大多和正樹, 内田龍児, 供田 洋, 長光 亨

      第9回北里化学シンポジウム  26 9 2015  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • Cyslabdanの全合成研究

      大多和正樹, 菱沼裕介, 内田龍児, 供田 洋, 長光 亨

      第9回北里化学シンポジウム  26 9 2015  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • 寄生虫選択性向上を志向した2’-atpenin A5誘導体の設計、合成及び活性評価

      大多和正樹, 矢野圭祐, 有馬志保, 大村 智, 長光 亨

      第9回北里化学シンポジウム  26 9 2015  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • 寄生虫選択性向上を志向した2’-置換atpenin A5誘導体の合成及び活性評価

      矢野圭祐, 大多和正樹, 有馬志保, 合田浩明, 広野修一, 大村 智, 長光 亨

      日本薬学会第135年会  28 3 2015  日本薬学会

      More details

      Language:Japanese   Presentation type:Oral presentation (general)  

      Venue:神戸  

      researchmap

    • 寄生虫選択性向上を志向したatpenin A5誘導体の設計、合成及び活性評価

      矢野圭祐, 大多和正樹, 有馬志保, 合田浩明, 広野修一, 大村 智, 長光 亨

      日本薬学会第135年会  27 3 2015  日本薬学会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:神戸  

      researchmap

    • Cyslabdanの全合成

      大多和正樹, 菱沼裕介, 内田龍児, 供田 洋, 長光 亨

      日本薬学会第135年会  27 3 2015  日本薬学会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:神戸  

      researchmap

    • Nafuredin-γの構造簡略型誘導体の合成研究

      有馬志保, 大多和正樹, 長光 亨

      第33回白金シンポジウム  16 12 2014  北里大学薬学部

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • Cyslabdanの全合成と構造決定

      大多和正樹, 長光 亨

      第33回白金シンポジウム  16 12 2014  北里大学薬学部

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • Design, synthesis, and biological evaluation of a novel atpenin A5 derivative as a complex II inhibitor

      Yano K, Miyao A, Ohtawa M, Arima S, Gouda H, Hirono S, Omura S, Nagamitsu T

      第32回メディシナルケミストリーシンポジウム  27 11 2014  日本薬学会医薬化学部会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:神戸  

      researchmap

    • Design and synthesis of A-ring truncated pyripyropene A analogs as potent ACAT2 inhibitors Invited

      Ohtawa M

      第32回メディシナルケミストリーシンポジウム  26 11 2014  日本薬学会医薬化学部会

      More details

      Language:Japanese   Presentation type:Oral presentation (invited, special)  

      Venue:神戸  

      researchmap

    • Cyslabdanの合成研究

      菱沼裕介, 酒井悠希, 伊藤文博, 大多和正樹, 供田 洋, 長光 亨

      第58回日本薬学会関東支部大会  4 10 2014  日本薬学会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京都町田市  

      researchmap

    • Nafuredin-γの構造簡略型誘導体の合成研究

      清水恵里, 清水理紗, 大多和正樹, 有馬志保, 大村 智, 長光 亨

      第58回日本薬学会関東支部大会  4 10 2014  日本薬学会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京都町田市  

      researchmap

    • Atpenin A5の構造活性相関研究

      矢野圭祐, 宮尾篤欣, 大多和正樹, 有馬志保, 大村 智, 長光 亨

      日本薬学会第134年会  29 3 2014  日本薬学会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:熊本  

      researchmap

    • Nafuredin-γの構造活性相関研究

      清水理紗, 清水恵里, 大多和正樹, 有馬志保, 大村 智, 長光 亨

      日本薬学会第134年会  29 3 2014  日本薬学会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:熊本  

      researchmap

    • 安定性向上を指向したNafuredin-γの構造活性相関研究

      有馬志保, 大多和正樹, 長光 亨

      第31回白金シンポジウム  17 12 2013  北里大学薬学部

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • ACAT2選択的阻害剤pyripyropene Aの構造簡略型誘導体の創製研究

      大多和正樹, 長光 亨

      第31回白金シンポジウム  17 12 2013  北里大学薬学部

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • Nafuredin-γの構造活性相関研究

      清水理紗, 清水恵里, 大多和正樹, 有馬志保, 大村 智, 長光 亨

      第8回北里化学シンポジウム  14 12 2013  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:神奈川  

      researchmap

    • Atpenin A5の構造活性相関研究

      矢野圭祐, 宮尾篤欣, 大多和正樹, 有馬志保, 大村 智, 長光 亨

      第8回北里化学シンポジウム  14 12 2013  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:神奈川  

      researchmap

    • ACAT2選択的阻害剤pyripyropene Aの構造簡略型誘導体の創製研究

      大多和正樹, 寺山富明, 大城太一, 福田隆志, 大村 智, 供田 洋, 長光 亨

      第8回北里化学シンポジウム  14 12 2013  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:神奈川  

      researchmap

    • Atpenin A5の構造活性相関研究

      矢野圭祐, 宮尾篤欣, 大多和正樹, 有馬志保, 大村 智, 長光 亨

      第31回メディシナルケミストリーシンポジウム  21 11 2013  日本薬学会医薬化学部会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:広島  

      researchmap

    • ACAT2選択的阻害剤pyripyropene Aの構造簡略型誘導体の創製研究

      大多和正樹, 寺山富明, 大城太一, 福田隆志, 大村 智, 供田 洋, 長光 亨

      第31回メディシナルケミストリーシンポジウム  21 11 2013  日本薬学会医薬化学部会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:広島  

      researchmap

    • Nafuredin-γの構造活性相関研究

      清水理紗, 清水恵里, 大多和正樹, 有馬志保, 大村 智, 長光 亨

      第31回メディシナルケミストリーシンポジウム  20 11 2013  日本薬学会医薬化学部会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:広島  

      researchmap

    • Nafuredin-γの誘導体合成研究

      清水理紗, 清水恵里, 大多和正樹, 有馬志保, 大村 智, 長光 亨

      第57回日本薬学会関東支部大会  26 10 2013  日本薬学会関東支部

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • NH4Fを用いた環状シリレンアセタールの位置選択的開環反応

      大多和正樹, 長光 亨

      日本薬学会第133年会  30 3 2013  日本薬学会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      researchmap

    • ACAT2選択的阻害剤pyripyropene A構造簡略型誘導体の合成研究

      寺山富明, 大野浩直, 大多和正樹, 松田大介, 大城太一, 福田隆志, 大村 智, 供田 洋, 長光 亨

      日本薬学会第133年会  29 3 2013  日本薬学会

      More details

      Language:Japanese   Presentation type:Oral presentation (general)  

      researchmap

    • ACAT2選択的阻害剤pyripyropene Aの全合成および創薬研究

      大多和正樹, 長光 亨

      第30回白金シンポジウム  18 12 2012  北里大学薬学部

      More details

      Language:Japanese   Presentation type:Poster presentation  

      第30回白金シンポジウム講演要旨集 p.6

      researchmap

    • Complex II選択的阻害剤atpenin A5の構造活性相関研究

      大多和正樹, 有馬志保, 長光 亨

      第30回白金シンポジウム  18 12 2012  北里大学薬学部

      More details

      Language:Japanese   Presentation type:Poster presentation  

      第30回白金シンポジウム講演要旨集 p.7

      researchmap

    • Structure-activity relationship of new pyripyropene A derivatives, inhibitors of acyl-CoA:cholesterol acyltranferase 2

      Ohtawa M, Matsuda D, Yamazaki H, Ohshiro T, Rudel L. L, Omura S, Tomoda H, Nagamitsu T

      13th Tetrahedron Symposium – Asia Edition, Taipei  29 11 2012 

      More details

      Language:English   Presentation type:Poster presentation  

      researchmap

    • Atpenin A5の構造活性相関研究

      宮尾篤欣, 樋浦 徹, 大多和正樹, 有馬志保, 大村 智, 長光 亨

      第30回メディシナルケミストリーシンポジウム  29 11 2012  日本薬学会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      researchmap

    • Nafuredin-γの構造活性相関研究

      清水理紗, 福永恵子, 松永麻理, 大多和正樹, 有馬志保, 大村 智

      第30回メディシナルケミストリーシンポジウム  29 11 2012  日本薬学会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      researchmap

    • Total synthesis of pyripyropene A

      Ohtawa M, Tomoda H, Omura S, Nagamitsu T

      13th Tetrahedron Symposium – Asia Edition, Taipei  28 11 2012 

      More details

      Language:English   Presentation type:Poster presentation  

      researchmap

    • Nafuredin-γの誘導体合成

      福永恵子, 清水理紗, 大多和正樹, 塩見和朗, 大村 智, 長光 亨

      日本薬学会第132年会  31 3 2012  日本薬学会

      More details

      Language:Japanese   Presentation type:Oral presentation (general)  

      Venue:札幌  

      researchmap

    • Atpenin A5の構造活性相関研究

      樋浦 徹, 杉山晃平, 大多和正樹, 塩見和朗, 大村 智, 長光 亨

      日本薬学会第132年会  31 3 2012  日本薬学会

      More details

      Language:Japanese   Presentation type:Oral presentation (general)  

      Venue:札幌  

      researchmap

    • 重要疾患に対する化合物ライブラリーの構築に向けた天然物の全合成研究

      長光 亨, 大多和正樹, 有馬志保, 針谷義弘

      第29回 白金シンポジウム  18 1 2012  北里大学薬学部

      More details

      Language:Japanese   Presentation type:Oral presentation (general)  

      researchmap

    • ACAT2選択的阻害剤pyripyropene Aの形式全合成

      石原雅織, 小谷篤輝, 大多和正樹, 大村 智, 供田 洋, 長光 亨

      AKPS集会第7回北里化学シンポジウム  22 12 2011  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • Pyripyropene Aの低分子化誘導体の合成研究

      寺山富明, 市田直樹, 大多和正樹, 大村 智, 供田 洋, 長光 亨

      AKPS集会第7回北里化学シンポジウム  22 12 2011  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • Atpenin A5の構造活性相関研究-1

      樋浦 徹, 杉山晃平, 大多和正樹, 塩見和朗, 大村 智, 長光 亨

      AKPS集会第7回北里化学シンポジウム  22 12 2011  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • Atpenin A5の構造活性相関研究-2

      宮尾篤欣, 樋浦 徹, 杉山晃平, 大多和正樹, 森 美穂子, 塩見和朗, 大村 智, 長光 亨

      AKPS集会第7回北里化学シンポジウム  22 12 2011  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • Nafuredin-γの誘導体合成

      福永恵子, 清水理紗, 大多和正樹, 塩見和朗, 大村 智, 長光 亨

      AKPS集会第7回北里化学シンポジウム  22 12 2011  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • NH<SUB>4</SUB>Fを用いた環状シリレンアセタールの位置選択的開環反応の検討

      大多和正樹, 長光 亨

      AKPS集会第7回北里化学シンポジウム  22 12 2011  北里大学

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:東京  

      researchmap

    • Stracture-activity Relationship of New Pyripyropene A Derivatives as Inhibitors of Acyl-CoA:cholesterole Acyltransferase 2

      Ohtawa M, Matsuda D, Yamazaki H, Ohshiro T, Omura S, Nagamitsu T, Tomoda H

      AIMECS11 8th AFMC International Medicinal Chemistry Symposium  1 12 2011  Asian Federation for Medicinal Chemistry

      More details

      Language:English   Presentation type:Poster presentation  

      Venue:Tokyo  

      researchmap

    • Atpenin A5の構造活性相関研究

      樋浦 徹, 大多和正樹, 森 美穂子, 塩見和朗, 大村 智, 長光 亨

      第55回日本薬学会関東支部大会  8 10 2011  日本薬学会

      More details

      Language:Japanese   Presentation type:Oral presentation (general)  

      Venue:千葉  

      researchmap

    • ACAT2選択的阻害剤pyripyropenAの構造活性相関ならびに全合成

      大多和正樹, 松田大介, 山崎寛之, 大城太一, 大村 智, 長光 亨, 供田 洋

      第53回天然有機化合物討論会  28 9 2011  日本化学会/日本薬学会/日本農芸化学会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      Venue:大阪  

      researchmap

    • Pyripyropene Aの新規低分子誘導体の合成研究

      市田直樹, 大多和正樹, 供田 洋, 長光 亨

      日本薬学会第131年会(静岡)  31 3 2011  日本薬学会

      More details

      Language:Japanese   Presentation type:Oral presentation (general)  

      researchmap

    • Pyripyropene Aの新規低分子誘導体の合成研究

      市田直樹, 大多和正樹, 供田 洋, 大村 智, 長光 亨

      第29回メディシナルケミストリーシンポジウム(京都)  17 11 2010  日本薬学会医薬化学部会

      More details

      Language:Japanese   Presentation type:Poster presentation  

      researchmap

    • Pyripyropene Aの新規低分子誘導体の合成研究

      市田直樹, 大多和正樹, 供田 洋, 大村 智, 長光 亨

      第54回日本薬学会関東支部大会(東京)  2 10 2010  日本薬学会関東支部

      More details

      Language:Japanese   Presentation type:Oral presentation (general)  

      researchmap

    • ACAT2選択的阻害剤ピリピロペン Aの誘導体合成と構造活性相関

      大多和正樹

      第5回医薬品原料国際展 医薬品化学研究発表大会〜アカデミックシンポジウム〜(東京)  30 6 2010  リードエグジビションジャパン株式会社

      More details

      Language:Japanese   Presentation type:Oral presentation (general)  

      researchmap

    • Structure-activity Relationship of New Pyripyropene A Derivatives, Inhibitors of Acyl-CoA:Cholesterol acyltransferase 2

      Ohtawa M, Matsuda D, Yamazaki H, Ohshiro T, Nagamitsu T, Omura S, Tomoda S

      The 21st French-Japanese Symposium on Medicinal and Fine Chemistry(Kyoto)  10 5 2010 

      More details

      Language:English   Presentation type:Poster presentation  

      researchmap

    • ACAT2選択的阻害剤pyripyropen Aの誘導体合成と構造活性相関

      大多和正樹, 福永恵子, 山崎寛之, 松田大介, 大城太一, 針谷義弘, 長光 亨, 大村 智, 供田 洋

      日本薬学会第130年会  29 3 2010  日本薬学会

      More details

      Language:Japanese  

      researchmap

    • NFRD阻害剤atpenin類の全合成並びに構造活性相関研究

      杉山晃平, 樋浦 徹, 大多和正樹, 針谷義弘, 長光 亨, 森 美穂子, 塩見和朗, 大村 智

      日本薬学会第130年会  29 3 2010  日本薬学会

      More details

      Language:Japanese  

      researchmap

    • 重要疾患に対する化合物ライブラリーの構築とリード化合物の創製

      長光 亨, 大多和正樹, 有馬志保, 針谷義弘

      第26回白金シンポジウム・北里大学薬学部「文部科学省ハイテク・リサーチ・センター整備事業」研究成果中間報告会  21 12 2009 

      More details

      Language:Japanese  

      researchmap

    • ACAT2選択的阻害剤pyripyropene Aの誘導体合成と構造活性相関

      大多和正樹, 福永恵子, 山崎寛之, 松田大介, 大城太一, 針谷義弘, 長光 亨, 大村 智, 供田 洋

      AKPS集会第6回北里化学シンポジウム  9 12 2009  北里大学

      More details

      Language:Japanese  

      researchmap

    • Fumaratereductas阻害剤atpenin類の全合成ならびに構造活性相関研究

      杉山晃平, 樋浦 徹, 大多和正樹, 針谷義弘, 森 美穂子, 塩見和朗, 長光 亨, 大村 智

      AKPS集会第6回北里化学シンポジウム  9 12 2009  北里大学

      More details

      Language:Japanese  

      researchmap

    • ACAT2選択的阻害剤pyripyropene Aの誘導体合成と構造活性相関

      大多和正樹, 山崎寛之, 松田大介, 大城太一, 針谷義弘, 長光 亨, 大村 智, 供田 洋

      第28回メディシナルケミストリーシンポジウム  25 11 2009  日本薬学会

      More details

      Language:Japanese  

      researchmap

    • Fumarate reductase阻害剤atpenin類の全合成ならびに構造活性相関研究

      杉山晃平, 樋浦 徹, 大多和正樹, 針谷義弘, 長光 亨, 森 美穂子, 塩見和朗, 大村 智

      第28回メディシナルケミストリーシンポジウム  25 11 2009  日本薬学会

      More details

      Language:Japanese  

      researchmap

    • Enantioselective total synthesis of atpenins

      Ohtawa M, Sugiyama K, Shiomi K, Harigaya Y, Nagamitsu T, Omura S

      The Eleventh International Kyoto Conference on New Aspects of Organic Chemistry  10 11 2009 

      More details

      Language:Japanese  

      researchmap

    • DNA傷害性シグナル伝達を阻害する pycnidioneの作用機構に関する研究

      金子真弓, 松田大介, 大多和正樹, 内田龍児, 長光 亨, 針谷義弘, 大村 智, 供田 洋

      日本薬学会第129年会  28 3 2009  日本薬学会

      More details

      Language:Japanese  

      researchmap

    • ACAT2選択的阻害剤pyripyropene A の誘導体合成と構造活性相関

      大多和正樹, 山崎寛之, 松田大介, 大城太一, 針谷義弘, 長光 亨, 大村 智, 供田 洋

      日本薬学会第129年会  27 3 2009  日本薬学会

      More details

      Language:Japanese  

      researchmap

    • ACAT2選択的阻害剤pyripyropene Aの誘導体合成と構造活性相関

      大多和正樹, 山崎寛之, 松田大介, 大城太一, 針谷義弘, 長光 亨, 大村 智, 供田 洋

      第27回メディシナルケミストリーシンポジウム  27 11 2008 

      More details

      Language:Japanese  

      researchmap

    • Atpenin類の全合成研究

      杉山晃平, 荻原 悟, 大多和正樹, 塩見和朗, 針谷義弘, 長光 亨, 大村 智

      第38回複素環化学討論会  22 11 2008 

      More details

      Language:Japanese  

      researchmap

    • Atpenin類の全合成研究

      杉山晃平, 荻原 悟, 大多和正樹, 塩見和朗, 針谷義弘, 長光 亨, 大村 智

      第52回日本薬学会関東支部大会若手シンポジウム  4 10 2008 

      More details

      Language:Japanese  

      researchmap

    ▼display all

    Professional Memberships

    Works

    • 3つのフラスコが世界を救う? (-)‐オセルタミビルの超効率的全合成

      大多和正樹

      1 7 2009

      More details

    Research Projects

    • ブテノリド特有の極性/ラジカル反応を駆使した天然物の革新的全合成研究

      日本学術振興会  科学研究費助成事業 

      大多和 正樹

      More details

      4 2024 - 3 2027

      Grant number:24K09714

      Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )

      researchmap

    • ブテノリドの性質を巧みに利用する新規反応開発とジベレリン類の短工程全合成研究

      科学研究費助成事業 基盤研究 (C) 

      大多和 正樹

      More details

      4 2021 - 3 2024

      Authorship:Principal investigator 

      researchmap

    • 新規天然有機化合物を基盤としたアムホテリシンB活性増強剤の創製研究

      科学研究費助成事業  基盤研究 (C) 

      大多和 正樹

      More details

      4 2018 - 3 2021

      Authorship:Principal investigator  Grant type:Competitive

      researchmap

    • イリシウムテルペノイド類の超効率的な全合成研究

      公益財団法人上原記念生命科学財団  リサーチフェローシップ 

      大多和 正樹

      More details

      4 2016 - 3 2018

      Authorship:Principal investigator  Grant type:Competitive

      researchmap

    • ACAT2選択的阻害剤pyripyropene A低分子型誘導体の創製研究

      科学研究費助成事業  基盤研究 (C) 

      大多和 正樹

      More details

      4 2013 - 3 2016

      Authorship:Principal investigator  Grant type:Competitive

      researchmap

    • Structure-activity relationship of atpenin A5 derivatives as complex II selective inhibitors

      Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research 

      OHTAWA Masaki

      More details

      4 2011 - 3 2013

      Grant number:23790140

      Authorship:Principal investigator  Grant type:Competitive

      Structure-activity relationship of atpenin A5 focused on 2-position and substituents of the side chain has been achieved. On this study, the importance of stereochemistry and the presence of each methyl and chloro groups on the side chain were elucidated.

      researchmap

    • ACAT2選択的阻害剤pyripyropene A低分子型誘導体の創製研究

      公益財団法人武田科学振興財団  薬学系研究奨励 

      大多和 正樹

      More details

      2012

      Authorship:Principal investigator  Grant type:Competitive

      researchmap

    • Synthesis and structure activity relationship of atpenin A5 derivatives as complex II inhibitors

      Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research 

      OHTAWA Masaki

      More details

      4 2009 - 3 2011

      Grant number:21790117

      Authorship:Principal investigator  Grant type:Competitive

      Comprehensive structure activity relationship of atpenin A5 as a potent complex II inhibitor and the synthesis of atpenin A5/flutolanil chimeric inhibitors has been achieved. On the guidance of this study, we also constructed a potential basis for the discovery of atpenin A5 derivatives as novel antihelminth agents.

      researchmap

    ▼display all

    Industrial property rights

    ▼display all

    Media Coverage

    • 化学者のつぶやき 「神経栄養/保護作用を有するセスキテルペン類の全合成研究」ースクリプス研究所 Ryan Shenvi研より Internet

      Chem-Station  https://www.chem-station.com/blog/2019/01/shenvi.html  1 2019

      More details